Tetrabenazine
- Generic Name
- Tetrabenazine
- Brand Names
- Nitoman, Xenazine
- Drug Type
- Small Molecule
- Chemical Formula
- C19H27NO3
- CAS Number
- 58-46-8
- Unique Ingredient Identifier
- Z9O08YRN8O
Overview
A drug formerly used as an antipsychotic but now used primarily in the symptomatic treatment of various hyperkinetic disorders. It is a monoamine depletor and used as symptomatic treatment of chorea associated with Huntington's disease. FDA approved on August 15, 2008.
Background
A drug formerly used as an antipsychotic but now used primarily in the symptomatic treatment of various hyperkinetic disorders. It is a monoamine depletor and used as symptomatic treatment of chorea associated with Huntington's disease. FDA approved on August 15, 2008.
Indication
Treatment of hyperkinetic movement disorders like chorea in Huntington's disease, hemiballismus, senile chorea, Tourette syndrome and other tic disorders, and tardive dyskinesia
Associated Conditions
- Gilles de la Tourette's Syndrome
- Hemiballismus
- Huntington's Disease (HD)
- Tardive Dyskinesia (TD)
- Senile chorea
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.